UBS Group »

Indaptus Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Indaptus Therapeutics (INDP) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Indaptus Therapeutics

Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025010k20k30k020004000
Value ($)Share countHistorical INDP position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Indaptus Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indaptus Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.1k 2.5k 0.84
2024-09-30 $647 522 1.24
2024-06-30 $1.5k 692 2.12
2024-03-31 $4.3k 1.9k 2.24
2023-12-31 $6.5k 3.7k 1.76
2023-09-30 $376 137 2.75
2023-06-30 $1.2k 640 1.91
2022-03-31 $13k 3.3k 3.95
2021-12-31 $28k 4.9k 5.68
2021-09-30 $1.0k 132 7.58